Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases. [Phase 3]
Phase 3 trial comparing tiotropium inhalation once daily versus salmeterol inhalation twice daily in COPD, evaluating arterial blood gases.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD [Phase 3]
A Phase 3 clinical trial evaluating the effects of nine months of SPIRIVA on health-related quality of life in patients with chronic obstruc…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 clinical trial update on tiotropium 18 mcg once daily via HandiHaler for chronic obstructive pulmonary disease. The study status i…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD [Phase 3]
A Phase 3 trial comparing tiotropium and ipratropium in adults with chronic obstructive pulmonary disease completed.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD [Phase 3]
A Phase 3 trial update reports on the efficacy and safety of tiotropium inhalation capsules in patients with chronic obstructive pulmonary d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease [Phase 3]
This entry reports the completion and posted results of a Phase 3 trial comparing Fluticasone Furoate/Vilanterol inhalation powder (FF/VI) t…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva [Phase 3]
This Phase 3 trial by Boehringer Ingelheim evaluated the acute bronchodilator response of ipratropium (Atrovent) or fenoterol (Berotec) adde…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease [Phase 4]
This Phase 4 clinical trial evaluates the efficacy of tiotropium in patients with chronic obstructive pulmonary disease, including a focus o…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD [Phase 3]
A Phase 3 trial comparing 5 mcg and 10 mcg doses of tiotropium delivered by Respimat against placebo and ipratropium MDI in chronic obstruct…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A six-week Phase 4 trial compares the efficacy and safety of tiotropium plus formoterol against salmeterol plus fluticasone in chronic obstr…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva) [Phase 3]
This document provides an update on a Phase 3 COPD trial evaluating tiotropium's ability to relieve dyspnea during exercise. The study was c…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Tiotropium (Spiriva) Rehabilitation Study [Phase 3]
A Phase 3 clinical trial investigating tiotropium for rehabilitation in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal). [Phase 4]
Phase 4 clinical trial update on Spiriva (tiotropium bromide) assessing FEV1 in chronic obstructive pulmonary disease; the SAFE-Portugal stu…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 clinical trial comparing tiotropium delivered via Respimat inhalation solution to Spiriva HandiHaler in chronic obstructive pulmonar…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled trial evaluated whether tiotropium inhalation capsules (Spiriva) improve exercise cap…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: SPIRIVA in Ususal Care [Phase 4]
A Phase 4 trial update shows the SPIRIVA study in usual care for COPD has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD [Phase 3]
Phase 3 trial comparing 5 mcg and 10 mcg tiotropium (Respimat) against placebo and ipratropium MDI in chronic obstructive pulmonary disease …
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders [Phase 3]
Phase 3 trial update evaluating the long-term effects of Spiriva (tiotropium) in acute respiratory disorders; the study sponsored by Boehrin…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: SCOPE-Study: Salzburg Chronic Obstructive Pulmonary Disease- Exercise and Oxygen Study [Phase 4]
An update on the Phase 4 SCOPE study evaluating exercise and oxygen therapy in COPD; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
A Phase 2 randomized, double-blind, crossover study of Ba679BR Respimat in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: High Dose Trial in COPD [Phase 2]
This update reports the completion of a phase 2 high-dose trial in chronic obstructive pulmonary disease sponsored by Boehringer Ingelheim.
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease [Phase 1]
A Phase 1 study evaluated the safety of MEDI2338 in subjects with chronic obstructive pulmonary disease. The trial has completed and results…
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: Portable Monitoring Device for the Diagnosis of Sleep Apnea in Patients With Chronic Obstructive Pulmonary Disease
A clinical trial evaluating a portable monitoring device for diagnosing sleep apnea in patients with chronic obstructive pulmonary disease h…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations [Phase 3]
Phase 3 trial comparing QVA149 (indacaterol/glycopyrronium) against NVA237 (glycopyrronium) and tiotropium on COPD exacerbations; results po…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]
This update covers a Phase 2, single-dose inhaled study of four AZD8683 dose levels in patients with Chronic Obstructive Pulmonary Disease. …